810106C

NBD AA

Avanti Research^™ - A Croda Brand 810106C

• Synonim(y): 20-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino] arachidonic acid
• Wzór empiryczny (zapis Hilla): C₂₆H₃₄ N₄O₅
• Numer CAS: 2254005-15-5
• Masa cząsteczkowa: 482.57
• Kod UNSPSC: 12352211
• NACRES: NA.25

Właściwości

• Próba: >99% (TLC)
• Postać: liquid
• opakowanie: pkg of 1 × 1 mL (810106C-1mg)
• producent / nazwa handlowa: Avanti Research^™ - A Croda Brand 810106C
• stężenie: 1 mg/mL (810106C-1mg)
• typ lipidu: fluorescent lipids; bioactive lipids
• Warunki transportu: dry ice
• temp. przechowywania: −70°C

Opis

Opis ogólny

The endocannabinoid pathway influences behavior, lipogenesis, embryologic development, and pathophysiological effects including pain, inflammation, stress, obesity, and non-alcoholic fatty liver disease. Endogenous endocannabinoids including arachidonoylethanolamide (anandamide, AEA) and 2-arachidonoylglycerol (2-AG) are derived from arachidonic acid (AA). Fluorescent NBD-AA and NBD-AEA analogues are direct probes that can be used for visualizing the uptake, intracellular trafficking, and targeting of these molecules by living cells, as well as measuring the binding of endocannabinoids to cytosolic binding proteins. Importantly, direct binding studies show the affinities of the fluorescent analogues are in the same range as the respective unlabeled ligands. Fluorescent endocannabinoid probes are useful for mapping the impact of various treatments, inhibitors, etc on endocannabinoid uptake and distribution in living cells.

Opakowanie

5 mL Amber Glass Screw Cap Vial/Argon/Foil Bag 810106C-1mg)

Informacje prawne

Avanti Research is a trademark of Avanti Polar Lipids, LLC

This page may contain text that has been machine translated.

Informacja o środkach bezpieczeństwa

• Piktogramy: GHS06,GHS08
• Hasło ostrzegawcze: Danger
• Zwroty wskazujące rodzaj zagrożenia: H302,H315,H319,H331,H336,H351,H361d,H372
• Zwroty wskazujące środki ostrożności: P260 - P280 - P301 + P312 + P330 - P304 + P340 + P311 - P305 + P351 + P338 - P403 + P233
• Klasyfikacja zagrożeń: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• Organy docelowe: Central nervous system
• Klasa zagrożenia wodnego (WGK): WGK 3